Stocks › B › BMNM

Bimini Capital Management, Inc. (BMNM) — Earnings Call X-Ray

Our AI read all 37 of BMNM's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q1 2025 · sign up to see
Previous Call Grade
C
Q4 2024
Expected Move
🔒
next 45 days · members
Calls Analyzed
37
2016–2025
Avg Candor
7.1/9
evasion 1.5/9
Critic AmmunitionReads RehearsedQuestion Left HangingResults Worse Than Direction

Call-by-call analysis

🔒 Q1 2025 earnings call 2025-05-02 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor ■/9
Specificity ■/9
Evasion ■/9
Stress ■/9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q1 2025 call grade is ready
The full 37-point AI read of BMNM's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C Q4 2024 earnings call 2025-03-07 move ±15.7%

Management gave no formal guidance against steady demand. The delivery was rich in specifics.

Demand: stable
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedDirection beats results
Candor 6/9
Specificity 7/9
Evasion 0/9
Confidence 5/9
Uncertainty 6/9
Promotion 3/9
Stress 2/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q3 2024 earnings call 2024-11-01

Management gave no formal guidance. The delivery was rich in specifics, relaxed under questioning.

Margins: stable
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsed
Candor 6/9
Specificity 8/9
Evasion 0/9
Confidence 5/9
Uncertainty 6/9
Promotion 2/9
Stress 1/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C+ Q2 2024 earnings call 2024-08-02

Management gave no formal guidance against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.

Demand: stableMargins: contractingPricing: under pressure
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable⚑ Reads rehearsedDirection beats results
Candor 7/9
Specificity 8/9
Evasion 0/9
Confidence 6/9
Uncertainty 5/9
Promotion 3/9
Stress 2/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B Q1 2024 earnings call 2024-05-03

Management gave no formal guidance against steady demand. The delivery was unusually candid, rich in specifics, relaxed under questioning.

Demand: stableMargins: stablePricing: stable
⚑ Critic ammunition✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsed
Candor 7/9
Specificity 8/9
Evasion 0/9
Confidence 6/9
Uncertainty 6/9
Promotion 2/9
Stress 1/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q4 2023 earnings call 2024-03-08

Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Demand: mixedMargins: contracting
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledDirection beats results
Candor 7/9
Specificity 8/9
Evasion 0/9
Confidence 5/9
Uncertainty 6/9
Promotion 2/9
Stress 3/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q3 2023 earnings call 2023-11-03

Management gave no formal guidance against contracting margins. The delivery was unusually candid, rich in specifics.

Margins: contractingPricing: under pressure
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledDirection beats results
Candor 8/9
Specificity 8/9
Evasion 1/9
Confidence 4/9
Uncertainty 7/9
Promotion 2/9
Stress 5/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q2 2023 earnings call 2023-08-11

Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Demand: mixedMargins: contractingCapex: increasing
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-led
Candor 7/9
Specificity 8/9
Evasion 0/9
Confidence 5/9
Uncertainty 6/9
Promotion 3/9
Stress 2/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q3 2023 2023-05-12 D noneunclearunclear 6/9 2/9
Q3 2022 2022-11-14 D noneslowingcontracting 8/9 2/9
Q2 2022 2022-08-12 C+ noneslowingcontracting 8/9 1/9
Q1 2022 2022-05-13 D noneslowingcontracting 8/9 2/9
Q4 2021 2022-03-11 C loweredslowingcontracting 8/9 1/9
Q3 2021 2021-11-14 B nonestablestable 7/9 0/9
Q2 2021 2021-08-13 C nonestableunclear 7/9 2/9
Q1 2021 2021-05-14 B+ raisedstableunclear 7/9 1/9
Q4 2020 2021-03-12 A raisedstableunclear 7/9 1/9
Q3 2020 2020-11-07 C nonestableexpanding 6/9 2/9
Q2 2020 2020-08-14 B+ nonestableunclear 7/9 1/9
Q1 2020 2020-05-15 C+ noneunclearcontracting 8/9 3/9
Q4 2019 2020-03-19 D noneunclearcontracting 7/9 2/9
Q3 2019 2019-11-11 C+ nonemixedunclear 8/9 2/9
Q2 2019 2019-08-10 C noneunclearcontracting 8/9 1/9
Q1 2019 2019-05-10 D maintainedstablecontracting 6/9 4/9
Q4 2018 2019-03-20 D noneslowingcontracting 8/9 4/9
Q3 2018 2018-11-02 C+ noneslowingcontracting 8/9 1/9
Q2 2018 2018-08-03 D noneslowingcontracting 7/9 2/9
Q1 2018 2018-05-11 D noneslowingcontracting 7/9 3/9
Q4 2017 2018-03-09 C+ noneslowingunclear 7/9 2/9
Q3 2017 2017-11-04 D nonestablecontracting 6/9 2/9
Q2 2017 2017-08-11 D nonemixedcontracting 7/9 2/9
Q1 2017 2017-05-11 C+ nonestableunclear 7/9 0/9
Q4 2016 2017-03-08 D noneunclearcontracting 7/9 2/9
Q3 2016 2016-11-11 C nonestablestable 7/9 2/9
Q2 2016 2016-08-10 C+ nonestableunclear 7/9 2/9
Q1 2016 2016-05-11 C noneunclearcontracting 7/9 1/9
Q4 2015 2016-03-22 C nonestableunclear 7/9 2/9

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAP · Advance Auto Parts, Inc.ABCAF · Athabasca Minerals, Inc.ABDC · Alcentra Capital'sABMD · Abiomed, Inc.ABNRY · ABN AMRO Bank N.V.ABOS · Acumen Pharmaceuticals,

← BMMJ   All “B” companies    BMO →

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.